Prescription drug · ANDA
Glipizide NDC 52817-385
Glipizide 2.5 mg/1 · Tablet · Oral · TruPharma LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 52817-385-10 | 52817038510 | 100 TABLET in 1 BOTTLE (52817-385-10)Marketed from Oct 3, 2023 | |
| 52817-385-50 | 52817038550 | 500 TABLET in 1 BOTTLE (52817-385-50)Marketed from Oct 3, 2023 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Glipizide
- Generic name (nonproprietary)
- glipizide
- Active ingredients
- Glipizide — 2.5 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- TruPharma LLC
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 214874
- Marketing start
- Listing expires
- Other FDA classes
- Sulfonylurea Compounds (Chemical structure)
- Identifiers
- Product ID 52817-385_076b74ec-ead5-781c-e063-6394a90ab362SPL ID 076b74ec-ead5-781c-e063-6394a90ab362SPL set ID 95ea4c96-84b9-4515-9494-a93d26820f70RxCUI 379804UNII X7WDT95N5CUPC 0352817385109, 0352817385505
- Pharmacologic class
- Sulfonylurea
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N452817038510followed by a unit qualifier and the quantityPackage 52817-0385-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Glipizide tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 214874
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Glipizide | Glipizide 15 mg/1 | TabletOral | Advagen Pharma Limited | 72888-231 |
| Glipizide | Glipizide 10 mg/1 | TabletOral | PD-Rx Pharmaceuticals, Inc. | 72789-463 |
| Glipizide | Glipizide 5 mg/1 | TabletOral | PD-Rx Pharmaceuticals, Inc. | 72789-464 |
| Glipizide | Glipizide 10 mg/1 | TabletOral | PD-Rx Pharmaceuticals, Inc. | 72789-510 |
| Glipizide | Glipizide 5 mg/1 | TabletOral | Proficient Rx LP | 82804-174 |
| Glipizide | Glipizide 5 mg/1 | TabletOral | Preferred Pharmaceuticals Inc. | 68788-4020 |
| Glipizide | Glipizide 10 mg/1 | TabletOral | Preferred Pharmaceuticals Inc. | 68788-4017 |
| Glipizide | Glipizide 10 mg/1 | TabletOral | Advanced Rx of Tennessee, LLC | 80425-0549 |
| Glipizide | Glipizide 10 mg/1 | TabletOral | A-S Medication Solutions | 50090-7734 |
| Glipizide | Glipizide 10 mg/1 | TabletOral | A-S Medication Solutions | 50090-7735 |
| Glipizide | Glipizide 10 mg/1 | TabletOral | NuCare Pharmaceuticals, Inc. | 68071-3974 |
| Glipizide | Glipizide 5 mg/1 | TabletOral | A-S Medication Solutions | 50090-7755 |
| Glipizide | Glipizide 5 mg/1 | TabletOral | A-S Medication Solutions | 50090-7756 |
| Glipizide | Glipizide 5 mg/1 | TabletOral | Advagen Pharma Limited | 72888-116 |
| Glipizide | Glipizide 2.5 mg/1 | TabletOral | Advagen Pharma Limited | 72888-115 |
| Glipizide | Glipizide 10 mg/1 | TabletOral | Advagen Pharma Limited | 72888-117 |
| Glipizide | Glipizide 5 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-2528 |
| Glipizide | Glipizide 10 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-2540 |